Neuropsychiatric970Million People
Global Prevalence Potential Indications Depression, Anxiety, Substance Abuse, Bipolar, Schizophrenia, PTSD Neuropsychiatric970Million People
Global Prevalence Potential Indications Depression, Anxiety, Substance Abuse, Bipolar, Schizophrenia, PTSD |
Neurological$800Billion
Cost Burden in the U.S. Potential Indications Parkinson's, Epilepsy, Alzheimer, Dementia, Multiple Sclerosis Neurological$800Billion
Cost Burden in the U.S. Potential Indications Parkinson's, Epilepsy, Alzheimer, Dementia, Multiple Sclerosis |
Neuromuscular90Percent
Agree to be a an unmet need Potential Indications Amyotrophic lateral sclerosis, Duchenne muscular dystrophy Neuromuscular90Percent
Agree to be a an unmet need Potential Indications Amyotrophic lateral sclerosis, Duchenne muscular dystrophy |